日本贸易振兴机构成都代表处考察四川汇宇制药股份有限公司

浏览次数:

发布时间:

2025-04-27

来源:

日本贸易振兴机构成都代表处考察四川汇宇制药股份有限公司

JETRO Chengdu Visits Sichuan Huiyu Pharmaceutical Co., Ltd.

 

2025年4月21日,日本贸易振兴机构(JETRO)成都代表处首席代表秋叶隆充先生、经理王植一女士及高级专员潘华臻先生一行莅临汇宇制药成都总部考察指导。汇宇制药集团副总裁张春平先生、CDMO总监廖晓明先生代表公司热情接待了代表处来访嘉宾。

On April 21, 2025, Mr. Takamitsu Akiha, Chief Representative of the Japan External Trade Organization (JETRO) Chengdu Office, along with Ms. Zhiyi Wang (Manager) and Mr. Huazhen Pan (Senior Officer), visited the headquarter of Huiyu Pharma in Chengdu. They were warmly received by Mr. Chunping Zhang, Vice President of Huiyu Group, and Mr. Xiaoming Liao, Director of CDMO.

日本贸易振兴机构成都代表处考察四川汇宇制药股份有限公司

座谈中,汇宇制药团队向JETRO介绍了公司与日本企业在原料药、注射剂开发与生产等领域的合作情况,分享了在国际化布局中的成果与经验,并表示希望在JETRO的支持下,进一步深化与更多日本医药企业的交流合作,实现互利共赢。

During the meeting, the Huiyu Pharma team introduced their ongoing collaborations with Japanese companies in the fields of API and injectable development and manufacturing. They also shared their achievements in global expansion and expressed their desire to further strengthen cooperation with Japanese pharmaceutical companies with the support of JETRO, aiming for mutual benefit and win-win partnerships.

日本贸易振兴机构成都代表处考察四川汇宇制药股份有限公司

汇宇制药诚挚欢迎更多日本制药企业来访交流,期待在开放合作中共同推动中日医药产业的高质量发展。

Huiyu Pharma sincerely welcomes more Japanese pharmaceutical companies to visit and exchange ideas, and looks forward to fostering high-quality development in the pharmaceutical industry between China and Japan through open collaboration.

 


分享到:

相关推荐

11-27
2025
国际肺癌关注月 | CT报告有“肺结节”?小汇带你读懂它,拆解“心结”肺癌,作为全球发病率和死亡率均极高的恶性肿瘤,每年都在夺走无数人的生命。每年11月是“国际...
11-24
2025
汇宇制药HY-0006和奥希替尼联合用药临床试验申请获受理近日,四川汇宇制药股份有限公司全资子公司四川汇宇海玥医药科技有限公司收到国家药品监督管理局核准签发的《...
11-19
2025
汇宇制药“依托泊苷注射液”获批上市近日,四川汇宇制药股份有限公司的 “依托泊苷注射液”(化学药品新3类)经国家药品监督管理局公告,批准上市,并视同通过一致性评价...
11-14
2025
@找工作的你,汇宇制药这些『硬核』岗位正在招人→ 一转眼又到年底还在被动等一个机会?期待心仪工作从天而降?是时候主动出击给自己一份‘硬核’的职业惊喜啦...